Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06496555

Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,100 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO) criteria. We designed five aspects including the overall fitting effecience evaluation, calibration curve, quantifying calibration performance, quantifying discrimination performance, quantifying clinical utility to evaluate the external validation model.

Conditions

Timeline

Start date
2024-06-01
Primary completion
2025-06-30
Completion
2025-12-31
First posted
2024-07-11
Last updated
2024-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06496555. Inclusion in this directory is not an endorsement.